Expression of the Ets-1 transcription factor in human astrocytomas is associated with fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5608-5614

  Valter, Markus M ^a,d   Hügel, Anja ^b   Huang, H J Su ^c   Cavenee, Webster K ^c   Wiestler, Otmar D ^a   Pietsch, Torsten ^a   Wernert, Nicolas ^a,b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TRANSLOCATION; GLIOMA CELL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; RECEPTOR GENE; TRANSACTIVATION; TUMOR VASCULARIZATION;

ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0344578062     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Guerin, C., and Laterra, J. Regulation of angiogenesis in malignant gliomas. Exper. Suppl. (Basel), 79:47-64, 1997.
2. Plate, K. H., and Risau, W. Angiogenesis in malignant gliomas. Glia, 3: 339-347, 1995.
3. Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Exper. Suppl. (Basel), 79:233-269, 1997.
4. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
5. Plate, K. H., and Warnke, P. C. Vascular endothelial growth factor. J. Neurooncol., 3: 365-372, 1997.
6. de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 5047: 989-991, 1992.
7. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 3: 1579-1586, 1992.
8. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond.), 6573: 435-439, 1996.
9. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., OqShea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 6573: 439-442, 1996.
10. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (Lond.), 6535: 66-70, 1995.
11. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (Lond.), 6535: 62-66, 1995.
12. Breier, G., Damen, A., Plate, K. H., and Risau, W. Angiogenesis in embryos and ischemic diseases. Thromb. Haemost., 1: 678-683, 1997.
13. Plate, K. H., Breier, G., and Risau, W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol., 3: 207-218, 1994.
14. Pietsch, T., Valter, M. M., Wolf, H. K., von Deimling, A., Huang, H. J., Cavenee, W. K., and Wiesller, O. D. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol., 2: 109-117, 1997.
15. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 6398: 845-848, 1992.
16. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., and Risau, W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 4: 520-529, 1994.
17. Hood, J., and Granger, H. J. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J. Biol. Chem., 36: 23504-23508, 1998.
18. Kroll, J., and Waltenberger, J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem., 51: 32521-32527, 1997.
19. Landgren, E., Schiller, P., Cao, Y., and Claesson-Welsh, L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1. Oncogene, 3: 359-367, 1998.
20. Seko, Y., Takahashi, N., Tobe, K., Ueki, K., Kadowaki, T., and Yazaki, Y. Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes. J. Cell. Physiol., 3: 239-246, 1998.
21. Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem., 2: 603-606, 1996.
22. Coffer, P., de Jonge, M., Mettouchi, A., Binetruy, B., Ghysdael, J., and Kruijer, W. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c- Ets-2. Oncogene, 3: 911-921, 1994.
23. Wasylyk, C., Bradford, A. P., Gutierrez-Hartmann, A., and Wasylyk, B. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and pointed P2. Oncogene, 8: 899-913, 1997.
24. Wasylyk, B., Hagman, J., and Gutierrez-Hartmann, A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci., 6: 213-216, 1998.
25. Yang, B. S., Hauser, C. A., Henkel, G., Colman, M. S., Van Beveren, C., Stacey, K. J., Hume, D. A., Maki, R. A., and Ostrowski, M. C. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol., 2: 538-547, 1996.
26. Chen, Z., Fisher, R. J., Riggs, C. W., Rhim, J. S., and Lautenberger, J. A. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res., 10: 2013-2019, 1997.
27. Iwasaka, C., Tanaka, K., Abe, M., and Sato, Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell. Physiol., 3: 522-531, 1996.
28. Grevin, D., Chen, J. H., Raes, M. B., Slehelin, D., Vandenbunder, B., and Desbiens, X. Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation. Int. J. Dev. Biol., 4: 519-529, 1993.
29. Vandenbunder, B., Pardanaud, L., Jaffredo, T., Mirabel, M. A., and Stehelin, D. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development, 2: 265-274, 1989.
30. Wemert, N., Raes, M. B., Lassalle, P., Dehouck, M. P., Gosselin, B., Vandenbunder, B., and Stehelin, D. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol., 1: 119-127, 1992.
31. Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M. B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B., and Stehelin, D. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res., 21: 5683-5688, 1994.
32. Maroulakou, I. G., Papas, T. S., and Green, J. E. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene, 6: 1551-1565, 1994.
33. Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C., and Stehelin, D. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature (Lond.), 5941: 395-397, 1983.
34. Nunn, M. F., Seeburg, P. H., Moscovici, C., and Duesberg, P. H. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature (Lond.), 5941: 391-395, 1983.
35. Dittmer, J., and Nordheim, A. Ets transcription factors and human disease. Biochim. Biophys. Acta, 2: F1-F11, 1998.
36. Macleod, K., Leprince, D., and Stehelin, D. The ets gene family. Trends Biochem. Sci., 7: 251-256, 1992.
37. Vandenbunder, B., Queva, C., Desbiens, X., Wernert, N., and Stehelin, D. Expression of the transcription factor c-Ets 1 correlates with the occurrence of invasive processes during normal and pathological development. Invasion Metastasis, 1-6: 198-209, 1994.
38. Wasylyk, C., Gutman, A., Nicholson, R., and Wasylyk, B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J., 5: 1127-1134, 1991.
39. Wakiya, K., Begue, A., Stehelin, D., and Shibuya, M. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor I) gene. J. Biol. Chem., 48: 30823-30828, 1996.
40. Kleihues, P., Burger, P. C., and Scheithauer, B. W. Histological typing of tumours of the central nervous system. New York: Springer Verlag, 1993.
41. Jorcyk, C. L., Watson, D. K., Mavrothalassitis, G. J., and Papas, T. S. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene, 4: 523-532, 1991.
42. Koizumi, S., Fisher, R. I., Fujiwara, S., Jorcyk, C., Bhat, N. K., Seth, A., and Papas, T. S. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene, 5: 675-681, 1990.
43. Wasylyk, B., Hahn, S. L., and Giovane, A. The Ets family of transcription factors (Published erratum in Eur. J. Biochem., 215: 907, 1993). Eur. J. Biochem., 211: 7-18, 1993.
44. Boulukos, K. E., Pognonec, P., Rabault, B., Begue, A., and Ghysdael, J. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol., 12: 5718-5721, 1989.
45. Watson, D. K., McWilliams, M. J., Lapis, P., Lautenberger, J. A., Schweinfest, C. W., and Papas, T. S. Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc. Natl. Acad. Sci. USA, 21: 7862-7866, 1988.
46. Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., and Cavenee, W. K. Suppression of glioblastoma angiogenicily and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 16: 8502-8507, 1996.
47. Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., and Strawn, L. M. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res., 7: 1615-1620, 1996.
48. Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., Krummen, L., Winkler, M., and Ferrara, N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res., 20: 4593-4599, 1997.
49. Abdulrauf, S. I., Edvardsen, K., Ho, K. L., Yang, X. Y., Rock, J. P., and Rosenblum, M. L. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J. Neurosurg., 3: 513-520, 1998.
50. Oka, T., Rairkar, A., and Chen, J. H. Structural and functional analysis of the regulatory sequences of the ets-1 gene. Oncogene, 11: 2077-2083, 1991.
51. Seth, A., and Papas, T. S. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene, 12: 1761-1767, 1990.
52. Barleon, B., Siemeister, G., Martiny-Baron, G., Weindel, K., Herzog, C., and Marme, D. Vascular endothelial growth factor up-regulales its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res., 23: 5421-5425, 1997.
53. Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., and Isner, J. M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Investig., 2: 469-476, 1996.
54. Kremer, C., Breier, G., Risau, W., and Plate, K. H. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res., 17: 3852-3859, 1997.
55. Waltenberger, J., Mayr, U., Pentz, S., and Hombach, V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia (see comments). Circulation, 7: 1647-1654, 1996.
56. DiSalvo, J., Bayne, M. L., Conn, G., Kwok, P. W., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A., and Thomas, K. A. Purification and characterization of a naturally occurring vascular endothelial growth factor, placenta growth factor heterodimer. J. Biol. Chem., 13: 7717-7723, 1995.
57. Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., and Ferrara, N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem., 10: 5638-5646, 1996.
58. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 43: 26988-26995, 1994.
59. Maru, Y., Yamaguchi, S., and Shibuya, M. Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials. Oncogene, 20: 2585-2595, 1998.
60. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 1: 135-147, 1995.
61. Delannoy-Courdent, A., Mattot, V., Fafeur, V., Fauquette, W., Pollet, I., Calmels, T., Vercamer, C., Boilly, B., Vandenbunder, B., and Desbiens, X. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J. Cell. Sci., 111: 1521-1534, 1998.
62. Bindal, A. K., Hammoud, M., Shi, W. M., Wu, S. Z., Sawaya, R., and Rao, J. S. Prognostic significance of proteolytic enzymes in human brain tumors. J. Neurooncol., 2: 101-110, 1994.
63. Rooprai, H. K., and McCormick, D. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res., 6B: 4151-4162, 1997.
64. Yong, V. W., Krekoski, C. A., Forsyth, P. A., Bell, R., and Edwards, D. R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci., 2: 75-80, 1998.
65. Yamamoto, M., Sawaya, R., Mohanam, S., Bindal, A. K., Bruner, J. M., Oka, K., Rao, V. H., Tomonaga, M., Nicolson, G. L., and Rao, J. S. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res., 14: 3656-3661, 1994